STUDresearch · Peptide
Vesilute
Also known as
ED peptide · Glu-Asp · Glu-Asp dipeptide · H-Glu-Asp-OH · ED dipeptide · Vesilut · Khavinson bladder peptide · bladder cytogen · A-12 synthetic counterpart
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Mixed
Oral / SubQ / IM
Organ bioregulators
Aimed at bladder tissue in the writeups, but people still swallow capsules or pin it like any other short peptide.
What people say
Vesilute is identified in originating-group molecular work as the synthetic Glu-Asp dipeptide ED. It must remain distinct from Chitomur or Vesusten cattle-bladder peptide extracts and from similarly named Vesugen and Visoluten.
Doses people talk about
Capsule counts without strength, milligram and microgram injection blogs, and a different-product clinical trial are not interchangeable or an endorsed progression.
How it may feel
Selected posters described less pain/nocturia on a Prostamax/Vesilute stack and stronger bladder function after one Vesilute round, but neither supplied a dependable onset and both had major co-interventions.
Legacy oral capsule chart2 capsules/day; strength not stated
A commenter described this as a general bioregulator schedule paired with a 30-day intensive course, not a Vesilute-specific effective amount; capsule milligrams were not established.
Legacy SubQ protocol-blog chart~1–2 mg SubQ once daily
The preserved chart pairs this with about 60 days and 2–3 courses per year, sometimes alongside Prostamax; it is not a human PK or controlled Vesilute outcome regimen.
Legacy microdose-blog outlier~100 mcg SubQ once daily
The preserved minority-blog schedule used 5 days on / 2 off for about 20 days; it remains an orders-of-magnitude outlier, not a validated comparison or recommendation.
Half-life & effect duration
- Half-life in the body
- Synthetic ED peptideNo settled estimate
- Felt duration people report
- Reported outcomesLess pain or nighttime urination in a stack; stronger bladder function after a round following surgery and therapy
Cycles people discuss
The old notes preserve short oral or injectable blocks and seasonal repeats. The reviewed Vesilute reports were described only as a course or one round; a separate commenter described a 30-day intensive calendar for bioregulators generally. None establishes an effective Vesilute cycle.
Timing
Oral capsule charts commonly place use with food or shortly before it. Morning versus bedtime is debated around night-time bathroom trips, without a settled preferred clock or a pharmacokinetic result resolving that debate.
Around the dose
Night log: People who care about nocturia track 3-day voiding / how many times they get up — not a “pump” selfie.
Stacks
Prostamax, Chitomur and Libidon are preserved neighbors in the old notes. One positive urinary report used Prostamax with Vesilute, so the result cannot be assigned to Vesilute alone.
Watch for
Do not drop real urology care: Retention, blood in urine, fever, or sudden inability to void is clinic territory, not a peptide log.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No human route-specific parent half-life for synthetic ED Vesilute was established.
Originating-group work identifies Vesilute as Glu-Asp and models peptide-DNA interaction; it does not report oral, SubQ or IM concentration-time sampling. The OAB clinical regimen located used different product Vesusten.
Molecular size and docking are not PK; product names, extract versus synthetic identity, route and formulation must remain separate.
- Short peptides regulate gene expression (opens in a new tab)Full PDF reviewed. The peptide/DNA tables identify Vesilute as ED (Glu-Asp) and present sequence-binding and docking/model results; the paper distinguishes named synthetic short peptides from tissue-extract product classes.Originating-group molecular and modeling research, not human urinary efficacy, consumer product authentication or route-specific pharmacokinetics.
- Vesusten plus mirabegron in women with overactive bladder (opens in a new tab)Full abstract page reviewed. The study regimen used Vesusten, described as a cattle-bladder peptide extract, 5 mg IM three times weekly for 10 injections with mirabegron in women with overactive bladder.Different peptide-extract product and combination treatment; not evidence for synthetic ED Vesilute dose equivalence, half-life or independent effect.
Felt duration people report
Selected reports describe urinary improvement but do not establish a Vesilute-only onset or felt duration.
One author attributed pain and nocturia improvement to a Prostamax/Vesilute stack; another reported stronger bladder function after one round following surgery and pelvic-floor therapy.
Sparse unverified reports, different products and routes, strong co-intervention and stack confounding, no voiding diary or controlled withdrawal.
- Vesilute use and capsule-course discussion (opens in a new tab)Full visible thread and same-author replies reviewed. A commenter said they had personally used Vesilute when PSA was slightly elevated but supplied no Vesilute-specific outcome or dose. In a separate general-bioregulator reply, the same author described two capsules daily for a 30-day intensive course and a 10-day maintenance course repeated every 3–6 months.Community use statement and general bioregulator schedule, with capsule strength, product identity and direct Vesilute outcome unstated; the calendar is not a Vesilute efficacy result.
- Prostate-health discussion including Prostamax and Vesilute (opens in a new tab)Full visible discussion reviewed. One commenter attributed disappearance of pain and reduction in nocturia from about three nightly trips to one or zero, with better sleep, to a Prostamax plus Vesilute stack; amount, route and timing were not stated.One uncontrolled two-product report with no verified diagnosis, product, amount, route or onset; cannot isolate Vesilute or generalize response.
- One-round Vesilute report after pelvic-health treatment (opens in a new tab)Full visible discussion reviewed. One commenter described a Vesilute round after pelvic-organ prolapse, hysterectomy and pelvic-floor therapy and reported stronger bladder function; route, dose and day of onset were not stated.One uncontrolled report with major prior interventions, unverified product and no objective measurement or washout.
What people say
- Nocturia / fewer night trips: The loudest n=1 — people log getting up less. Stacks, sleep, and prostate meds steal the credit. anecdote
- Urinary comfort reports: One poster attributed less pain and nocturia to a Prostamax/Vesilute stack; another described stronger bladder function after one Vesilute round following prolapse, hysterectomy and pelvic-floor therapy. The reviewed threads did not substantiate the old precise 30-day null claim. forum
- Prostate stack halo: Often paired with Prostamax or Libidon so nobody knows which name did what. forum
- Course culture, not a daily forever drug: People describe a block, then a break, then maybe a re-run — not oxybutynin-every-night energy. forum
- Nulls exist: r/OveractiveBladder-adjacent peptide posts include “spent the money, 30 days, no change.” anecdote
- What talk does not prove: Reversing obstruction, replacing alpha-blockers, or fixing infection. forum
- Flow / BPH-adjacent: Hunter-Williams-style writeups cite older Russian BPH/OAB series (flow-rate and IPSS-style scores). Single-source, not a modern Western RCT everyone can pull. trial
Doses people talk about
- Oral capsules (cytogen/cytomax culture): 1–2 capsules once or twice daily with meals for ~20–30 days is the copy-paste calendar. Capsule milligrams are not interchangeable across brands. forum
- Hunter-Williams-style subq: ~1–2 mg subcutaneous daily for ~60 days, 2–3 courses/year, often next to Prostamax at the same milligram story. forum
- Lower daily inject talk: Peptide-dosing blogs ~1–2 mg once daily; some reconstitution pages use ~1.5 mg/day for a short two-week block. forum
- Microdose outlier: A minority blog (Tony Huge–class) ran ~100 mcg subq daily, 5 on / 2 off, ~20 days — orders of magnitude under the milligram charts. anecdote
- Reddit spread: r/Peptides comments on bioregulators swing from hundreds of mcg to multi-mg; one injectable log landed ~750 mcg daily for ~26 days. forum
- X stack example: One 2026 reply talked 4 mg Vesugen with 4 mg Vesilute, split 2 mg AM / 2 mg PM of each. n=1, not a standard. anecdote
- Unit chaos: 20 mg vials vs 10 mg capsules vs “100 mcg” tweets. Copying another Khavinson name’s milligrams onto ED is a common error. forum
- Different-product boundary: A 2025 overactive-bladder trial used Vesusten 5 mg intramuscular three times weekly for 10 injections alongside mirabegron. Vesusten is a cattle-bladder peptide extract, not synthetic ED Vesilute, so this regimen must not be presented as a Vesilute dose. trial
- Framing: Forum, protocol-blog, and vendor-chart ranges only — not a label, not medical advice. forum
How it may feel
- Days 1–3: Usually nothing dramatic. Logistics (pin sting or capsule) beat any bladder feel. forum
- Onset is not established: Reviewed posters described improvement after a Vesilute-containing course or one round but did not give a dependable day of onset. One account combined Prostamax, and another followed surgery and pelvic-floor therapy. forum
- End of a 2–4 week inject block: Common checkpoint on protocol blogs (10-injection IM charts, or daily subq for a few weeks). forum
- Oral 20–30 day capsule block: The cytogen/cytomax calendar people copy from other Khavinson names. forum
- Weeks after the course: Gene-expression lore says the feel can linger. Public logs rarely keep a voiding diary with a washout. forum
- No change: People usually blame product, dose-unit confusion (mcg vs mg), or the wrong organ name — not automatic mega-dose. forum
Around the dose
- Night log: People who care about nocturia track 3-day voiding / how many times they get up — not a “pump” selfie. forum
- Not a skip-the-alpha-blocker move: Community realists keep tamsulosin / pelvic PT / caffeine cuts in the picture. forum
- Pairing: Prostamax is the named bladder-prostate neighbor. Ventfort shows up when the same person is running a vessel calendar. forum
Cycles people discuss
- Short inject block: ~10–20 days, or a 10-injection IM course, then off. forum
- Longer daily subq: ~4–8 week daily pins in some protocol blogs. forum
- Oral month: ~20–30 days of capsules, repeated a few times a year. forum
- Re-runs: 2–3 courses/year is the longevity-calendar talk, not continuous forever. forum
- With Chitomur: Some people run the synthetic (Vesilute) then the tissue complex (Chitomur), or pick one. forum
Timing
- Size is not PK: Vesilute is identified as the Glu-Asp dipeptide in originating-group molecular work, but molecular size and docking models do not establish human oral, SubQ or IM clearance. Daily course charts are schedules, not half-life measurements. trialforum
- Why short courses anyway: Same Khavinson story as Vesugen — gene-expression lore claims the feel outlasts blood peptide. forum
- Clock talk: Night-trip logs make bedtime vs morning a live argument. No PK settles it. forum
- With meals (oral): Capsule charts usually say with food or shortly before. forum
- PK honesty: No solid public human half-life package for synthetic ED. trial
More on what it is
- What it is: Synthetic dipeptide Glu-Asp (ED). ~262 Da. CAS 3918-84-1. Khavinson-line bladder/urogenital cytogen — the short synthetic, not the animal-tissue complex. forum
- Not Vesugen: Vesugen is Lys-Glu-Asp (KED) for vessels. Same naming family, different sequence, different organ story. Mixing the two is a common search fail. forum
- Not Visoluten: Visoluten is the retina cytomax. Vesilute is bladder. One letter, wrong organ. forum
- Not Chitomur: Chitomur (A-12) is the natural bladder-tissue peptide complex. Vesilute is the synthetic ED dipeptide people treat as the faster cytogen counterpart. forum
- Why people search it: Night peeing, urgency, BPH-adjacent flow, and “bladder peptide” threads next to Prostamax / Libidon. forum
- Not: Not oxybutynin, not tamsulosin, not a pelvic-floor program, not a UTI antibiotic. forum
- Evidence honesty: English-language independent RCTs are thin. Originating-group urology writeups and vendor/protocol blogs do most of the talking. trial
Stacks
- Prostamax: The bladder-prostate pair Hunter-Williams-style posts keep repeating. forum
- Chitomur: Tissue-complex counterpart. Same organ story, different product class. forum
- Libidon: Prostate cytomax in male urinary calendars. forum
- Ventfort / Vesugen: Vessel peptides in the same multi-organ rotation — one 2026 X log ran Vesugen + Vesilute the same days. forum
- Pielotax: Kidney bioregulator in older-male urinary stacks. forum
- Not a substitute for: Alpha-blockers, 5-ARIs, pelvic-floor work, or UTI care. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Overall: Short-peptide culture calls it “just amino acids.” That is marketing, not a safety package. forum
- Injection site: Redness, sting, itch — technique and diluent. forum
- GI (oral): Mild stomach noise on capsule courses, same as other cytogens. forum
- Wrong-name risk: Grabbing Vesugen or Visoluten by autocomplete. forum
- mg vs mcg: 100 mcg blogs vs 5 mg IM charts. Easy to overshoot. forum
- Do not drop real urology care: Retention, blood in urine, fever, or sudden inability to void is clinic territory, not a peptide log. forum
- Pregnancy / breastfeeding: No adequate data; research-only exclusion in vendor fine print. forum
- Source risk: Gray-market sequence and fill errors. forum
- Regulatory: Not FDA/EMA approved for OAB, BPH, or nocturia. trial
- Research-only framing: Discussion of community practice — not a recommendation to use in humans or animals. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.